{"id":649468,"date":"2023-04-27T19:42:01","date_gmt":"2023-04-27T19:42:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=649468"},"modified":"2023-04-27T19:42:01","modified_gmt":"2023-04-27T19:42:01","slug":"cell-therapy-technology-market-is-expected-to-reach-87-billion-by-2028-an-exclusive-market-research-report-by-lucintel","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/cell-therapy-technology-market-is-expected-to-reach-87-billion-by-2028-an-exclusive-market-research-report-by-lucintel_649468.html","title":{"rendered":"Cell Therapy Technology Market is expected to reach $8.7 Billion by 2028 – An exclusive market research report by Lucintel"},"content":{"rendered":"
\n
\"Cell<\/a><\/div>\n
\n
Trends and Forecast for the Cell Therapy Technology Market <\/div>\n<\/div>\n<\/div>\n
Trends, opportunities, and forecast for the global cell therapy technology market from 2017 to 2028 by product (media, sera, and reagents, cell engineering products, cell culture vessels, cell therapy equipment, and others), process (cell processing, cell preservation, distribution and handling, and process monitoring and quality control), cell type (T-cell, stem cell, and others), end use industry (biopharmaceutical and biotechnology companies, and others), and region<\/div>\n

Lucintel’s latest market report analyzed that cell therapy technology<\/a> provides attractive opportunities in biopharmaceutical and biotechnology companies, CROs & CMOs, and research institutes & cell banks. The cell therapy technology market is expected to reach $8.7 billion by 2028 with a CAGR of 14.5%. In this market, stem cell is the largest segment by cell type, whereas research institutes and cell bank is largest by end use industry.<\/p>\n

Download Brochure<\/strong> of this report by clicking on https:\/\/www.lucintel.com\/cell-therapy-technology-market.aspx<\/a><\/p>\n

Based on cell type, the cell therapy technology market is segmented into T-cell, stem cell, and others. The stem cell segment accounted for the largest share of the market in 2023 and is expected to register the highest CAGR during the forecast period, due to the increasing need for therapies for neurological diseases and growing awareness of stem cell storage.<\/p>\n

Browse in-depth TOC on “Cell Therapy Technology Market”<\/p>\n

100 – Figures\/Tables<\/p>\n

150 – Pages<\/p>\n

The Cell Therapy Technology Market is marked by the presence of several big and small players. Some of the prominent players offering cell therapy technology include Pharmicell, Corestem, Chiesi Farmaceutici, Tego Science, and Anterogen.<\/p>\n

Request Sample Report:<\/strong><\/p>\n

https:\/\/www.lucintel.com\/cell-therapy-technology-market.aspx<\/a><\/p>\n

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@lucintel.com<\/a>.<\/p>\n

About Lucintel<\/strong><\/p>\n

Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com<\/a>.<\/p>\n

Roy Almaguer <\/em>Lucintel Dallas, Texas, USA Email: roy.almaguer@lucintel.com  Tel. 972.636.5056<\/p>\n

Media Contact<\/span>
Company Name:<\/strong> Lucintel<\/a>
Contact Person:<\/strong> Roy Almaguer
Email:<\/strong> Send Email<\/a>
Phone:<\/strong> 972.636.5056
Address:<\/strong>8951 Cypress Waters Blvd., Suite 160
City:<\/strong> Dallas
State:<\/strong> TEXAS
Country:<\/strong> United States
Website:<\/strong> https:\/\/www.lucintel.com\/<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

Trends and Forecast for the Cell Therapy Technology Market Trends, opportunities, and forecast for the global cell therapy technology market from 2017 to 2028 by product (media, sera, and reagents, cell engineering products, cell culture vessels, cell therapy equipment, and … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[405,429,417,411,416],"tags":[],"class_list":["post-649468","post","type-post","status-publish","format-standard","hentry","category-Health-Medicine","category-Hospitality","category-Marketing-Sales","category-Technology","category-World"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/649468","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=649468"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/649468\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=649468"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=649468"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=649468"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}